B. Zaki

发表

Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma.

Jennifer J. Gibson, R. Barth, T. Colacchio, 2008, Journal of the American College of Surgeons.

Multicenter, Open-Label, Phase II Study of Bendamustine and Rituximab Followed by 90-Yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma (Fol-BRITe)

T. Mackenzie, Youdinghuan Chen, F. Lansigan, 2019, Clinical Cancer Research.

Treatment of Patients With Late-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline

S. Park, S. Temin, A. Croitoru, 2020, JCO global oncology.

Effect of initiating a multidisciplinary care clinic on access and time to treatment in patients with pancreatic adenocarcinoma.

Amitabh Srivastava, T. Gardner, Kerrington D. Smith, 2010, Journal of oncology practice.

ACR Practice Parameter for the Performance of Therapy With Unsealed Radiopharmaceutical Sources.

B. Franc, D. Spratt, J. Osborne, 2016, Clinical nuclear medicine.

The impact of particulate electron paramagnetic resonance oxygen sensors on fluorodeoxyglucose imaging characteristics detected via positron emission tomography

A. Flood, P. Kuppusamy, E. Demidenko, 2021, Scientific Reports.

Repeated monitoring of tumor oxygen while breathing carbogen to determine the therapeutic potential of hyperoxic therapy.

D. Gladstone, H. Swartz, B. Williams, 2013, Practical radiation oncology.

Hyperfractionated radiotherapy and paclitaxel for locally advanced/unresectable pancreatic cancer.

H. Ashamalla, B. Zaki, M. Krishnamurthy, 2003, International journal of radiation oncology, biology, physics.

Patterns of Utilization and Clinical Adoption of 0.35 MR-Guided Radiation Therapy in the United States - Understanding the Transition to Adaptive, Ultra-Hypofractionated Treatments.

R. Mak, P. Parikh, L. Portelance, 2021, International journal of radiation oncology, biology, physics.

DNA-damage response during mitosis induces whole-chromosome missegregation.

J. Murnane, D. Compton, S. Bakhoum, 2014, Cancer discovery.

DNA damage response during mitosis induces whole chromosome mis-segregation

J. Murnane, D. Compton, S. Bakhoum, 2014 .

Radioactive gold grain implants in recurrent and locally advanced head-and-neck cancers.

S. Rafla, H. Ashamalla, B. Zaki, 2002, Brachytherapy.

Fractionated Stereotactic Radiotherapy Boost and Weekly Paclitaxel in Malignant Gliomas Clinical and Pharmacokinetics Results

L. Lewis, H. Ashamalla, D. Dosik, 2007, Technology in cancer research & treatment.

ACR-ABS-ACNM-ASTRO-SIR-SNMMI practice parameter for selective internal radiation therapy or radioembolization for treatment of liver malignancies.

K. Hong, P. Devlin, C. Trimmer, 2021, Brachytherapy.

Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma.

M. Korc, T. Gardner, Kerrington D. Smith, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

VEGF remains an interesting target in advanced pancreas cancer ( APCA ) : results of a multi-institutional phase II study of bevacizumab , gemcitabine , and infusional 5-fl uorouracil in patients with APCA

M. Korc, T. Gardner, S. Gordon, 2012 .

Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations.

C. Amos, W. Wells, T. Gardner, 2014, Clinical chemistry.

Chromosomal instability portends superior response of rectal adenocarcinoma to chemoradiation therapy

S. Bakhoum, A. Eastman, A. Suriawinata, 2014, Cancer.

Endovascular recanalization of symptomatic portomesenteric venous obstruction after pancreaticoduodenectomy and radiation.

J. Gemery, J. Pipas, B. Zaki, 2009, Journal of vascular and interventional radiology : JVIR.

Docetaxel/Gemcitabine Followed by Gemcitabine and External Beam Radiotherapy in Patients With Pancreatic Adenocarcinoma

M. Bettmann, R. Perez, J. Cates, 2005, Annals of Surgical Oncology.

Cost-effectiveness and clinical efficacy of biliary stents in patients undergoing neoadjuvant therapy for pancreatic adenocarcinoma in a randomized controlled trial.

T. Gardner, Kerrington D. Smith, S. Gordon, 2016, Gastrointestinal endoscopy.

Palliative and pain medicine: radiation oncology

B. Zaki, 2005 .

Successful retreatment with chemoradiotherapy for local recurrence of pancreatic adenocarcinoma after neoadjuvant therapy and pancreaticoduodenectomy.

S. Gordon, G. Tsongalis, A. Suriawinata, 2013, Gastrointestinal cancer research : GCR.

Electron Paramagnetic Resonance Dosimetry for a Large-Scale Radiation Incident

Ann Barry Flood, Harold M. Swartz, Benjamin B. Williams, 2012, Health physics.

Physically-based biodosimetry using in vivo EPR of teeth in patients undergoing total body irradiation

Thomas P. Matthews, R. J. Nicolalde, David J Gladstone, 2011, International journal of radiation biology.

Numerical chromosomal instability mediates susceptibility to radiation treatment

Ashley M. Laughney, Christopher D. Laucius, J. Murnane, 2015, Nature Communications.

Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines.

T. Tosteson, C. Fadul, B. Cole, 2009, Clinical colorectal cancer.

Initial Clinical Experience of Cherenkov Imaging in EBRT Identifies Opportunities to Improve Treatment Delivery.

Irwin I. Tendler, B. Pogue, D. Gladstone, 2020, International journal of radiation oncology, biology, physics.

Stereotactic MR-Guided On-Table Adaptive Radiation Therapy (SMART) for Patients with Borderline or Locally Advanced Pancreatic Cancer: Primary Endpoint Outcomes of a Prospective Phase II Multi-Center International Trial

P. Parikh, A. Raldow, J. Mancias, 2022, International Journal of Radiation Oncology*Biology*Physics.

Initial Observation of Contrast Profiles for 2D and 3D MRI Sequences in MR-Guided Radiation Therapy for Locally Advanced Pancreatic Cancer

Brett Williams, B. Zaki, B. Hunt, 2023, medRxiv.

Clinical EPR: unique opportunities and some challenges.

Steven G Swarts, Lesley A Jarvis, Benjamin B Williams, 2014, Academic radiology.

Use of the Toxicity Index in Evaluating Adverse Events in Anal Cancer Trials

J. Ajani, G. Yothers, L. Kachnic, 2022, American journal of clinical oncology.

Clinical electron paramagnetic resonance (EPR) oximetry using India ink.

Benjamin B Williams, Harold M Swartz, Alan Hartford, 2010, Advances in experimental medicine and biology.

The Effect of Neoadjuvant Chemoradiation on Pancreatic Cancer-Associated Diabetes Mellitus

T. Gardner, Kerrington D. Smith, S. Gordon, 2014, Pancreas.

Physically-based biodosimetry using in vivo EPR of teeth in patients undergoing total body irradiation

Thomas P. Matthews, R. J. Nicolalde, D. Gladstone, 2011, International journal of radiation biology.

ACR-ABS-ACNM-ASTRO-SIR-SNMMI practice parameter for selective internal radiation therapy or radioembolization for treatment of liver malignancies.

K. Hong, P. Devlin, C. Trimmer, 2021, Brachytherapy.

A Multi-Institutional Phase II Trial of Ablative 5-Fraction Stereotactic MR-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.

P. Parikh, A. Raldow, J. Mancias, 2023, International journal of radiation oncology, biology, physics.

Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments

A. Kishan, R. Mak, P. Parikh, 2022, Clinical and Translational Radiation Oncology.

Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: a multi-center, open-label phase 2 study.

A. Raldow, J. Mancias, L. Boldrini, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.